Fundz
Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Bio Matrix Specialty Infusion Pharmacy Appoints Ted Kramm As Chief Executive Officer and Kathee Kramm As President

PRIVATEJun 25, 2024•almost 2 years ago

Position

Chief Executive Officer

Company

BioMatrix Infusion Pharmacy

Ted Kramm
PlantationBiotechnologyHealth CareMedical

Description

BioMatrix Specialty Infusion Pharmacy announced the sale of majority interests to Frazier Healthcare Partners and the appointment of Ted Kramm as its new Chief Executive Officer, with Kathee Kramm assuming the role of President. The appointment aims to facilitate the continued growth in the infusion pharmacy arena.

Company Information

Company

BioMatrix Infusion Pharmacy

Location

Plantation, Florida, United States

About

BioMatrix Infusion Pharmacy is a leading provider in ambulatory and home infusion services. It specializes in delivering high-quality, patient-centered care to individuals with complex medical conditions. The company is dedicated to enhancing access to infused medications and improving patient outcomes through its extensive services. With decades of experience, BioMatrix focuses on continuity of care and optimal clinical results.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for BioMatrix Infusion Pharmacy's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.